Laurent Poirot is an immunologist with over 15 years of experience in biotech.
In graduate school, he studied immunology in the laboratory of Diane MATHIS and Christophe BENOIST (Université de Strasbourg, France and Harvard Medical School, Boston, MA). His PhD thesis focused on the pathogenic mechanisms of autoimmune diabetes.
In 2004, he joined the Genomics Institute of the Novartis research foundation (GNF, San Diego, CA) as a postdoctoral fellow where he performed high-throughput genetic/genomic studies in immune cells (cDNA/siRNA screens, mouse mutagenesis, microarray databases).
In 2009, he joined Cellectis (Paris, France) where he first studied gene therapy approaches in hematopoietic stem cells and developed gene editing tools for CAR T-cells. In 2013, he became Head of Early Discovery and in 2018, VP Immunology division. His team develops innovative tools to improve immunotherapies based on gene-edited CAR T cells. He splits his activities between Paris and New-York.